Methodological issues of corticosteroid use in SLE clinical trials (Q33777440)

29 July 2017

1 reference

title

Methodological issues of corticosteroid use in SLE clinical trials (English)

1 reference

29 July 2017

2

S C Bae

1 reference

29 July 2017

M Corzillius

1

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

8

1 reference

29 July 2017

issue

8

1 reference

29 July 2017

page(s)

692-697

1 reference

Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Epileptogenic activity of folic acid after drug induces SLE (folic acid and epilepsy)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Glucocorticosteroid therapy: mechanisms of action and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

On the various forms of corticosteroid withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Allocation of subjects in medical experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

Randomisation and baseline comparisons in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/096120399680411407

10.1191/096120399680411407

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference